Mostrar el registro sencillo del ítem

Artículo

dc.creatorMontero Pérez, Olallaes
dc.creatorSalazar González, Fernandoes
dc.creatorSánchez Gómez, Ernestoes
dc.creatorPérez Guerrero, María Concepciónes
dc.date.accessioned2024-04-26T10:39:12Z
dc.date.available2024-04-26T10:39:12Z
dc.date.issued2024-04-21
dc.identifier.citationMontero Pérez, O., Salazar González, F., Sánchez Gómez, E. y Pérez Guerrero, M.C. (2024). Impact of pharmaceutical care for asthma patients on health‐related outcomes: An umbrella review. Pharmacology Research & Perspectives, 12 (3), e1195. https://doi.org/10.1002/prp2.1195.
dc.identifier.issn2052-1707es
dc.identifier.urihttps://hdl.handle.net/11441/157198
dc.description.abstractRecent systematic reviews suggest that pharmacists' interventions in asthma patients have a positive impact on health-related outcomes. Nevertheless, the association is not well established, and the role of clinical pharmacists is poorly represented. The aim of this overview of systematic reviews is to identify published systematic reviews assessing the impact of pharmacists' interventions on healthrelated outcomes measured in asthma patients. PubMed, Embase, Scopus, and Cochrane Library were searched from inception to December 2022. Systematic reviews of all study designs and settings were included. Methodological quality was assessed using AMSTAR 2. Two investigators performed study selection, quality assessment and data collection independently. Nine systematic reviews met the inclusion criteria. Methodological quality was rated as high in one, low in two, and critically low in six. Reviews included 51 primary studies reporting mainly quality of life, asthma control, lung capacity, and therapeutic adherence. Only four studies were carried out in a hospital setting and only two reviews stated the inclusion of severe asthma patients. The quality of the systematic reviews was generally low, and this was the major limitation of this overview of systematic reviews. However, solid evidence supports that pharmaceutical care improves health-related outcomes in asthma patients.es
dc.formatapplication/pdfes
dc.format.extent12 p.es
dc.language.isoenges
dc.publisherWiley Open Accesses
dc.relation.ispartofPharmacology Research & Perspectives, 12 (3), e1195.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectasthmaes
dc.subjectclinical pharmacistes
dc.subjectoutcome assessmentes
dc.subjecthealth carees
dc.subjectpharmaceutical carees
dc.subjectsystematic reviewes
dc.titleImpact of pharmaceutical care for asthma patients on health‐related outcomes: An umbrella reviewes
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Farmacologíaes
dc.relation.publisherversionhttps://doi.org/10.1002/prp2.1195es
dc.identifier.doi10.1002/prp2.1195es
dc.journaltitlePharmacology Research & Perspectiveses
dc.publication.volumen12es
dc.publication.issue3es
dc.publication.initialPagee1195es

FicherosTamañoFormatoVerDescripción
Pharmacology Res Perspec - ...910.1KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional